Alnylam Pharmaceuticals shares owned by Fox Run Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Fox Run Management
from 13F filings
Historical chart of Fox Run Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Fox Run Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $794k | 2.9k | 275.03 |
| 2024-03-31 | $447k | 3.0k | 149.45 |
| 2023-06-30 | $531k | 2.8k | 189.94 |
| 2021-06-30 | $330k | 1.9k | 169.49 |
| 2019-09-30 | $690k | 9.5k | 72.52 |
| 2019-06-30 | $690k | 9.5k | 72.52 |
| 2018-06-30 | $969k | 9.8k | 98.52 |
| 2017-12-31 | $356k | 2.8k | 127.14 |
| 2017-09-30 | $540k | 4.6k | 117.39 |
| 2016-12-31 | $258k | 6.9k | 37.39 |
| 2016-09-30 | $522k | 7.7k | 67.79 |
More positions owned by Fox Run Management
Cigna Corp (CI)
View all positions for Fox Run Management